213 citations
,
December 2020 in “Annals of internal medicine” This study observed that 32% of COVID-19 patients experienced persistent symptoms, including fatigue, dyspnea, and loss of taste or smell, 30 to 45 days after their initial diagnosis.
29 citations
,
October 2020 in “Journal of the European Academy of Dermatology and Venereology” This article is a discussion piece that examines the clinical symptoms of hyperandrogenic women with COVID-19, without reporting new research findings.
21 citations
,
May 2021 in “Prostate Cancer and Prostatic Diseases” This review analyzes the potential mechanisms by which SARS-CoV-2 may exacerbate symptoms of benign prostatic hyperplasia and suggests a connection via ACE2 and androgen receptor pathways; it reports no new clinical results.
2 citations
,
September 2022 in “Frontiers in Nutrition” This study found no significant difference in the persistence of new symptoms or quality of life improvements with 200,000 IU of vitamin D3 compared to placebo in patients post-COVID-19 hospitalization.
In this study, patient-reported flare symptoms after COVID-19 vaccination in individuals with systemic lupus erythematosus were generally mild, with 17% experiencing flares mostly characterized by joint pain and fatigue; vaccine type did not affect flare incidence.